0.363
0.00 (0.61%)
| Previous Close | 0.361 |
| Open | 0.352 |
| Volume | 312,796 |
| Avg. Volume (3M) | 1,440,326 |
| Market Cap | 19,538,814 |
| Price / Book | 2.42 |
| 52 Weeks Range | |
| Earnings Date | 7 Aug 2025 |
| Diluted EPS (TTM) | 0.090 |
| Current Ratio (MRQ) | 3.36 |
| Operating Cash Flow (TTM) | -21.82 M |
| Levered Free Cash Flow (TTM) | -12.51 M |
| Return on Assets (TTM) | -124.39% |
| Return on Equity (TTM) | -19.56% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | ProMIS Neurosciences Inc. | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 27.56% |
| % Held by Institutions | 28.80% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ally Bridge Group (Ny) Llc | 30 Sep 2025 | 6,233,497 |
| Allostery Investments Lp | 30 Jun 2025 | 155,720 |
| Graypoint Llc | 30 Jun 2025 | 52,833 |
| Fiduciary Trust Co | 30 Sep 2025 | 28,583 |
| Howard Financial Services, Ltd. | 30 Sep 2025 | 26,042 |
| 52 Weeks Range | ||
| Median | 5.00 (1,277.03%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Guggenheim | 18 Nov 2025 | 5.00 (1,277.03%) | Buy | 0.360 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |